StandardAero enters the first week of June with two simultaneous shocks: a bellwether downgrade and a CEO change that together sent the stock down 8% on Tuesday alone.
The catalyst was a Jefferies call filed Monday. Analyst Sheila Kahyaoglu lowered her rating from Buy to Hold and cut her price target from $34 to $30 — a meaningful step back from a firm that had been constructive on the name. The timing was deliberate: that same morning, StandardAero announced Paul McElhinney as incoming CEO, with the transition effective October 1. The Jefferies move crystallised what the market was already beginning to ask. Current CEO Russ Ford's departure creates a period of strategic uncertainty, and Kahyaoglu's cut to the sidelines signals that at least one influential voice wants to see how the handover unfolds before re-engaging.
The wider analyst picture tells a more layered story. Nine firms still rate the stock Buy and three Hold, with a consensus price target near $35.60 — still 42% above Tuesday's close of $25.14. But the direction of target revisions has been consistently lower since Q1 results landed in May. Morgan Stanley trimmed to $34 from $35. Susquehanna cut to $37 from $40. RBC moved to $34 from $37. UBS upgraded to Buy in May but simultaneously reduced its target from $35 to $34. Taken together, the Street remains fundamentally bullish but is quietly de-rating the stock. The EV/EBITDA multiple has declined nearly a full turn over 30 days to 11.1x, consistent with that gradual re-rating. Bears point to the LEAP engine program's contribution carrying forward with compressed CRS margins and the risk that airline spending softens; bulls anchor on the MRO aftermarket durability and the Q1 print that beat on revenue — sales of $1.627B comfortably cleared the $1.485B estimate — while raising full-year guidance to $6.325B-$6.450B in sales and $1.40-$1.50 in adjusted EPS.
Short positioning has been building steadily, though it is not yet at a level that dominates the narrative. Short interest climbed 42% over the past month to 5.5% of the free float — roughly 18.3 million shares — driven in large part by the re-rating pressure that followed Q1. The week-on-week pace has slowed, with SI down about 2% from the prior Tuesday's level, suggesting the initial wave of new short selling has found an equilibrium for now. Borrowing conditions remain easy: cost to borrow is just 0.50%, and availability stands at nearly 297% — almost three shares available to borrow for every one currently short — leaving ample headroom for further short-side positioning if sentiment deteriorates. The ORTEX short score of 56.7 is moderate, ranking in the bottom 9th percentile of the universe by short-score ranking, which reflects the building but not extreme short pressure.
Options sentiment tilts firmly toward calls rather than puts. The put/call ratio is at 0.14, only marginally above its 20-day average of 0.14 and statistically near neutral with a z-score of 0.13. The 52-week range on the PCR runs from 0.025 to 1.22, so the current reading is far toward the bullish end of the historical distribution. That divergence from the short-side build is notable. Options traders are not pricing significant downside protection despite the leadership transition and analyst downgrade — a signal that the options market views Tuesday's move as event-driven rather than the start of a structural breakdown.
Institutional ownership adds another layer of complexity. The Carlyle Group retains a 25.4% stake — as primary backer from the October 2024 IPO, its position is locked-in rather than discretionary, but its continued presence sets a price anchor. T. Rowe Price added aggressively in Q1, bringing its holding to 15.8% of shares, while BlackRock and State Street both added materially in the most recent reporting period. These are not exits. Insider activity from April 16 was uniformly sell-side, with CEO Ford, the CFO, COO, and Chief Strategy Officer all booking sales at $27.36 — but the values were small (Ford's sale totalled just $291,000) and the significance scores were minimal, consistent with programmatic vesting-related sales rather than a directional read.
The next earnings event is confirmed for June 25. Given Q1's mixed picture — GAAP EPS missed but adjusted EPS beat, revenue well ahead — the upcoming print will be watched for how effectively McElhinney's appointment is framed as a continuation of the growth story rather than a disruption to it. The degree to which the Street's bullish consensus holds into that print, and whether the $35 average target survives another round of revisions, will define SARO's near-term trajectory.
See the live data behind this article on ORTEX.
Open SARO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
